医学
便秘
临床试验
聚乙二醇
双盲
传统医学
替代医学
内科学
病理
化学工程
工程类
安慰剂
作者
Elaheh Hajiarabi,Samaneh Khatibshahidi,Farzaneh Motamed,Fatemeh Farahmand,Mojgan Tansaz
标识
DOI:10.1089/acm.2014.5208.abstract
摘要
The Journal of Alternative and Complementary MedicineVol. 20, No. 5 Clinical ResearchComparison of Polyethylene Glycol 3350 and Product Made from Saccharum Officinarum L. for Treatment of Chronic Constipation; A Double-Blind Clinical TrialElaheh Hajiarabi, Samaneh Khatibshahidi, Farzaneh Motamed, Fatemeh Farahmand, and Mojgan TansazElaheh HajiarabiSearch for more papers by this author, Samaneh KhatibshahidiSearch for more papers by this author, Farzaneh MotamedSearch for more papers by this author, Fatemeh FarahmandSearch for more papers by this author, and Mojgan TansazSearch for more papers by this authorPublished Online:7 May 2014https://doi.org/10.1089/acm.2014.5208.abstractAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Comparison of Polyethylene Glycol 3350 and Product Made from Saccharum Officinarum L. for Treatment of Chronic Constipation; A Double-Blind Clinical Trial." The Journal of Alternative and Complementary Medicine, 20(5), p. A79FiguresReferencesRelatedDetailsCited byPrevention and treatment of constipation in children from the perspective of Iranian traditional medicineJournal of Integrative Medicine, Vol. 14, No. 6 Volume 20Issue 5May 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Elaheh Hajiarabi, Samaneh Khatibshahidi, Farzaneh Motamed, Fatemeh Farahmand, and Mojgan Tansaz.Comparison of Polyethylene Glycol 3350 and Product Made from Saccharum Officinarum L. for Treatment of Chronic Constipation; A Double-Blind Clinical Trial.The Journal of Alternative and Complementary Medicine.May 2014.A79-A79.http://doi.org/10.1089/acm.2014.5208.abstractPublished in Volume: 20 Issue 5: May 7, 2014PDF download
科研通智能强力驱动
Strongly Powered by AbleSci AI